Parathyroidectomy for secondary hyperparathyroidism in chronic kidney disease: a retrospective study of predictors of persistence and postoperative outcomes [0.03%]
慢性肾脏病继发性甲状旁腺功能亢进的手术治疗：持续性和术后结果预测因素的回顾性研究
Sanda Mrabet,Amyra Sakay,Radhouane Mani et al.
Sanda Mrabet et al.
From renal biopsy to genetic diagnosis: EYA1 mutation in branchio-oto-renal syndrome with renal insufficiency [0.03%]
从肾活检到基因诊断：眼耳面-耳-肾综合征伴肾功能不全的EYA1突变
Miao Yang,Mengqiu Lu,Huiliang Feng et al.
Miao Yang et al.
Association of sleep habits with Alpha-MSH levels in patients with chronic kidney disease [0.03%]
睡眠习惯与慢性肾脏病患者α-黑素细胞刺激激素水平的关系研究
Tugba Kandemir,Mahmut Gok
Tugba Kandemir
Background: Our study aims to compare Alpha-MSH (α-MSH) levels and their relationship with sleep state in cases with and without chronic kidney disease (CKD). ...
Use of tocilizumab to treat IgA nephropathy complicated by idiopathic multicentric Castleman disease: a case report [0.03%]
托珠单抗治疗免疫性多中心卡斯特利曼病合并IgA肾炎的疗效观察：1例报告
Yuichiro Komeno,Toshiaki Usui,Kohei Inoue et al.
Yuichiro Komeno et al.
Complete kidney allograft extrusion through a dehiscent wound following graft thrombosis and immunosuppression withdrawal: a case report [0.03%]
移植肾血栓形成和免疫抑制剂撤除后移植肾全肾排出的1例报告
Islam K Madadov,Dilmurat Akhmetov,Elshad S Nabiev et al.
Islam K Madadov et al.
The association between computed tomography-based intrapancreatic fat deposition and renal function [0.03%]
基于CT的胰腺内脂肪沉积与肾功能之间的关联性研究
Dingzhe Zhang,Yiping Zhang,Xin Chen et al.
Dingzhe Zhang et al.
Evaluation of tenofovir alafenamide- versus tenofovir disoproxil fumarate-containing regimens on renal outcomes: systematic literature review and meta-analysis [0.03%]
评估比夫定和恩曲他滨联用与替诺福韦地胺和恩曲他滨联用对肾脏结局的影响：系统文献回顾和荟萃分析
Xi Liang,Kyu Yun Park,Haeseon Lee et al.
Xi Liang et al.
Patient reported barriers and facilitators of chronic kidney disease care in Sub-Saharan Africa: a mixed methods systematic review using the COM-B model [0.03%]
撒哈拉以南非洲地区慢性肾脏病护理的患者报告障碍与促进因素：使用COM-B模型的混合方法系统评价
Habtamu Abera Areri,Leul Derbie Ketaw,Hailemariam Berhe et al.
Habtamu Abera Areri et al.
Background: In Sub-Saharan Africa (SSA), the prevalence of chronic kidney disease (CKD) is on the rise. Treatment for CKD in SSA is characterized by delayed initiation, early discontinuation, inadequate duration of therap...
Therapeutic strategies for olfactory impairment in patients with chronic kidney disease: a systematic review [0.03%]
慢性肾脏病患者嗅觉障碍的治疗策略：系统综述
Kamyar Iravani,Tahereh Fereydoonnezhad,Aida Doostkam et al.
Kamyar Iravani et al.
Background: Olfactory impairment is often considered a minor complication of chronic kidney disease (CKD), carrying important consequences for nutrition, safety, and overall quality of life. While several therapeutic stra...
Comparative efficacy and safety of finerenone in diabetic kidney disease: a meta-analysis of Asian and non-Asian populations [0.03%]
菲奈莫德治疗糖尿病肾病的疗效和安全性种族差异的Meta分析研究
Syed Abbas Raza,Aziz-Ur Rehman,Azizul Hasan Aamir et al.
Syed Abbas Raza et al.
Background & objective: Diabetic kidney disease (DKD) is a major global burden, especially in Asia. This study aimed to evaluate the efficacy and safety of finerenone in diabetic kidney disease, comparing outcomes between...